Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
about
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complexVirion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick GetawaySpecific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule.Positively Selected Sites at HCMV gB Furin Processing Region and Their Effects in Cleavage Efficiency.A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120.Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropismGlycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation.Cytomegalovirus-mediated activation of pyrimidine biosynthesis drives UDP-sugar synthesis to support viral protein glycosylationEnhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.THY-1 Cell Surface Antigen (CD90) Has an Important Role in the Initial Stage of Human Cytomegalovirus InfectionCrystal Structure of the Human Cytomegalovirus Glycoprotein B.Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.The human cytomegalovirus UL37 immediate-early regulatory protein is an integral membrane N-glycoprotein which traffics through the endoplasmic reticulum and Golgi apparatusMutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone bindingSynthetic DNA approach to cytomegalovirus vaccine/immune therapyHCMV gB shares structural and functional properties with gB proteins from other herpesviruses.Anti-idiotypic mimicry of a neutralizing epitope on the glycoprotein B complex of human cytomegalovirus.Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus.The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specificVaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigenCell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody responseIdentification and expression of a human cytomegalovirus early glycoprotein.Conservation of the glycoprotein B homologs of the Kaposi׳s sarcoma-associated herpesvirus (KSHV/HHV8) and old world primate rhadinoviruses of chimpanzees and macaquesRecombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cellsCleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells.Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B.Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7.Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture.Disulfide bond configuration of human cytomegalovirus glycoprotein B.Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.Glycoprotein Bb, the N-terminal subunit of bovine herpesvirus 1 gB, can bind to heparan sulfate on the surfaces of Madin-Darby bovine kidney cells.Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus.Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells.An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection.
P2860
Q21089588-FDFDCC78-8AAD-4473-BFDE-EC97715AF807Q26745798-D2D10CC4-615C-4830-AC2D-5AE3CDF9A204Q31035724-C8E463BE-2287-4379-9381-5E823A910934Q33717651-426D8A53-533D-42B5-9D8B-07D1C0A58590Q33935010-B3A75C88-0622-492F-9CEF-9FB348507A49Q34146374-247199C5-9563-4B94-A584-5F317954786BQ34212879-9F541B25-EBC1-48F9-A7DA-C526182EEADCQ34468958-3809D1E6-C28C-40AC-BA1B-A7A80B923788Q34717818-77FD897F-1B71-4162-A3EA-44E993B86531Q34752212-C93E6AE0-CCA1-467C-8863-92D3DB0DBA7DQ35111320-2DDB90C2-7F46-4B0F-A590-FF51DCD474FFQ35683719-1AFA524F-276B-4DDB-B4A2-7902B8B5058DQ35814428-5AEEAC9B-B493-4C77-856B-E12C51346F55Q35850918-F9FD5587-3F16-4E0C-8BFB-A31C3D05F125Q35870987-7C9FA015-0C3E-4F05-9FF5-5D16AFF54619Q35872566-DE4F8B4C-28BF-4D04-B753-80770AE4096FQ36069582-56DCA28D-C635-45A9-B6C5-AA08155AC900Q36501775-86C69AE2-1AAE-48CD-A07E-9A0443957F75Q36654615-8A2C7CFC-CFDE-4F65-8B38-3B0365ED23BCQ36685373-F0FEE263-A630-4A5D-9F0C-DE1BE42EEF80Q36687838-A40A52C1-03CC-4270-8EF9-FC614E96E7BAQ36691252-AE96A436-2A50-445F-AB02-45A6B193F203Q36694861-92347006-E216-4E32-ABBC-C0C7EAD22574Q36699001-CA174ECB-543A-4B46-AC1E-D754488BBB0AQ36802016-C01B503A-6814-4254-AFFA-E0D9142821FAQ36829799-6D3F547A-33B9-4E24-BDEA-124D0E99A5C6Q36945437-543E7576-4FF8-45E2-976A-A13097CA67FFQ37093594-2098D44B-D9A8-408A-89DD-248F17606D7AQ37252878-E9EB8267-E9C0-4CB8-BFD5-57C32C6F83E6Q37400431-6842F1E0-8D10-43B3-A6DE-D157AAF6D51FQ38359718-1ED6B972-74C9-45CF-B868-9B23A47EE9ECQ39577652-F1DA3DA2-97DA-4A4B-9DAD-810A11AA3F26Q39626155-1864C75B-CBCF-4B1F-B8F1-905CB19382DEQ39682047-37CF32DA-EF9F-4F63-9685-3CDACDDB7A01Q39683804-80CEB609-3E28-4E39-A72B-54483354A6ACQ39846393-74CD6ECE-F2E3-4602-AC7F-025B5FB28EE1Q39873901-1125B69F-D0D7-4553-9EF6-211C1C20913BQ40039564-18B2DEDE-696D-4886-8A84-BC36BAB842CEQ40042916-2B59B4B2-8C16-41B1-8E69-BBB7B9C2C366Q40045592-56F9CEB3-10B6-4CA7-8C2C-FECC58FC5F51
P2860
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
@ast
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
@en
type
label
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
@ast
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
@en
prefLabel
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
@ast
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
@en
P2860
P1433
P1476
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
@en
P2093
P2860
P304
P407
P577
1989-01-01T00:00:00Z